Methocarbamol NDC 85477-101

NDC codes

FDA NDC Directory

Product NDC (as listed)85477-101Labeler and product segments. Claims need a package NDC.

Product NDC at billing width85477-0101Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
85477-101-10	85477010110	100 TABLET, COATED in 1 BOTTLE, PLASTIC (85477-101-10)Marketed from Nov 20, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methocarbamol
Generic name (nonproprietary): methocarbamol
Active ingredients: Methocarbamol — 1000 mg/1
Dosage form: Tablet, Coated
Route: Oral
Labeler: Oncora Pharma, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 200958
Marketing start: Nov 20, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Centrally-mediated Muscle Relaxation (Physiologic effect)
Identifiers: Product ID 85477-101_440d6c53-6c13-3f8d-e063-6294a90a2a2bSPL ID 440d6c53-6c13-3f8d-e063-6294a90a2a2bSPL set ID 440d6c99-8aca-af07-e063-6294a90aee3dRxCUI 2611794UNII 125OD7737X
Pharmacologic class: Muscle Relaxant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N485477010110 followed by a unit qualifier and the quantity

Package 85477-0101-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 20, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Methocarbamol is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 200958

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 200958
Product	Strength	Form · route	Labeler	Product NDC
Methocarbamol	Methocarbamol 1000 mg/1	Tablet, CoatedOral	Trifluent Pharma LLC	73352-510
Methocarbamol	Methocarbamol 1000 mg/1	Tablet, CoatedOral	Misemer Pharmaceutical	0276-0510
Methocarbamol	Methocarbamol 750 mg/1	Tablet, CoatedOral	Bostal LLC	35561-211
Methocarbamol	Methocarbamol 500 mg/1	Tablet, CoatedOral	Bostal LLC	35561-212
Methocarbamol	Methocarbamol 1000 mg/1	Tablet, CoatedOral	Bostal LLC	35561-349